Napolitano, Maddalena http://orcid.org/0000-0003-3309-8190
Ferrucci, Silvia Mariel http://orcid.org/0000-0002-6734-1366
Foggia, Luciano
Hansel, Katharina http://orcid.org/0000-0002-6674-4278
Pezzolo, Elena http://orcid.org/0000-0003-0121-4812
Stingeni, Luca
Antonelli, Elettra
Picone, Vincenzo http://orcid.org/0000-0002-8137-8392
Patruno, Cataldo http://orcid.org/0000-0001-8661-2822
Article History
Accepted: 6 December 2023
First Online: 17 December 2023
Declarations
:
: No funding was received to conduct this study. For some of the patients, AbbVie provided the drug upadacitinib through a compassionate use programme activated according to the DM 7/9/2017.
: MN acted as speaker, consultant and advisory board member for Sanofi, Abbvie, Lilly, Leo Pharma and Pfizer; S.M.F. is speaker of Novartis and Sanofi Genzyme, is principal investigator for Eli Lilly, AbbVie, Sanofi Genzyme, and is an advisory member of Sanofi Genzyme; L.S. acted as speaker and board member for Sanofi-Genzyme; C.P. acted as investigator, speaker, consultant and advisory board member for AbbVie, Eli Lilly, Novartis, Pfizer, Pierre Fabre and Sanofi. The other authors have no competing interests to declare.
: Approval of this study was obtained by the Local Ethics Committee (Prot. N. 116/20, approved on December 5, 2022).
: The patients in this manuscript have given written informed consent to participate in the study.
: The patients in this manuscript have given written informed consent to publication of their case details.
: All data are reported in the current study.
: Not applicable.
: All authors made substantial contribution to this manuscript and in detail: MN conceptualized, designed the study, analysed and interpretated the data and drafted the article; SMF, KH, EP and EA acquired data and clinically managed patients; LF and VP performed statistical analysis of data with graphical and tabular conceptualization; LS and CP reviewed the article critically for important intellectual content. All authors read and approved the final version of the manuscript.